TREG provides expert education services and bespoke consultancy to the pharmaceutical industry, delivering high-level, interpretive analyses of the latest clinical and translational research on systemic autoimmune and inflammatory diseases, with the ultimate goal of optimizing patient care.
TREG’s highly experienced international faculty provides an in-depth, interpretive appraisal of the latest fundamental science and translational, clinical and observational research, providing meaningful clinical context for the best use of established and novel therapies for the benefit of patients.
Since 2009, TREG’s unrivaled Conference Analysis Program has provided high-level interpretation of the evidence presented at the two key rheumatology congresses – the American College of Rheumatology (ACR) and European Alliance of Associations for Rheumatology (EULAR) – bridging the gap between research and practical application.
Our education services and bespoke consultancy provide our industry partners with invaluable clinical insights and specialist advice tailored to their specific products and business needs.
